SEC EDGAR Filing Information

Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend]

Filing Date Changed: 2008-02-14
Documents: 2

SEC Accession No.
0000932440-08-000140
Filing date: 2008-02-14
Accepted: 2008-02-14 13:56:22

Table of submitted documents:

Seq	Type	Document	Size	Description
1	SC 13G/A	sch13g_1262332.htm	205423	SCHEDULE 13G AMENDED
2	EX-99	exh99-1_1262345.htm	28101	EXHIBIT 99.1 JOINT FILING AGREEMENT

		0000932440-08-000140.txt	235552	Complete submission text file

Filer Information:

AVANIR PHARMACEUTICALS (Subject) (0000858803)
IRS No.: 330314804 | State of Incorp.: CA | Fiscal Year End: 0930
Type: SC 13G/A | Act: 34 | File No.: 005-41430 | Film No.: 08612721
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
101 ENTERPRISE
SUITE 300
ALISO VIEJO CA 92656
949-389-6700

Mailing Address
101 ENTERPRISE
SUITE 300
ALISO VIEJO CA 92656

Ridgeback Capital Investments L.P. (Filed by) (0001423994)
IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G/A | Act: | Film No.:

Business Address
430 PARK AVENUE
12TH FLOOR
NEW YORK NY 10022
212-624-2567

Mailing Address
430 PARK AVENUE
12TH FLOOR
NEW YORK NY 10022